Dynamic Palmitoylation of the Sodium-Calcium Exchanger Modulates Its Structure, Affinity for Lipid-Ordered Domains, and Inhibition by XIP.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
09 06 2020
Historique:
received: 03 01 2020
revised: 07 04 2020
accepted: 06 05 2020
entrez: 11 6 2020
pubmed: 11 6 2020
medline: 20 5 2021
Statut: ppublish

Résumé

The transmembrane sodium-calcium (Na-Ca) exchanger 1 (NCX1) regulates cytoplasmic Ca levels by facilitating electrogenic exchange of Ca for Na. Palmitoylation, the only reversible post-translational modification known to modulate NCX1 activity, controls NCX1 inactivation. Here, we show that palmitoylation of NCX1 modifies the structural arrangement of the NCX1 dimer and controls its affinity for lipid-ordered membrane domains. NCX1 palmitoylation occurs dynamically at the cell surface under the control of the enzymes zDHHC5 and APT1. We identify the position of the endogenous exchange inhibitory peptide (XIP) binding site within the NCX1 regulatory intracellular loop and demonstrate that palmitoylation controls the ability of XIP to bind this site. We also show that changes in NCX1 palmitoylation change cytosolic Ca. Our results thus demonstrate the broad molecular consequences of NCX1 palmitoylation and highlight a means to manipulate the inactivation of this ubiquitous ion transporter that could ameliorate pathologies linked to Ca overload via NCX1.

Identifiants

pubmed: 32521252
pii: S2211-1247(20)30650-1
doi: 10.1016/j.celrep.2020.107697
pmc: PMC7296346
pii:
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
LAMTOR5 protein, human 0
Sodium-Calcium Exchanger 0
sodium-calcium exchanger 1 0
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107697

Subventions

Organisme : British Heart Foundation
ID : PG/18/60/33957
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/19/5/34150
Pays : United Kingdom
Organisme : British Heart Foundation
ID : SP/16/3/32317
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/14/68/30988
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Nat Chem Biol. 2015 Mar;11(3):192-4
pubmed: 25622090
J Biol Chem. 2009 Nov 20;284(47):32735-41
pubmed: 19801651
Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8500-5
pubmed: 24912166
Pflugers Arch. 2009 Aug;458(4):653-60
pubmed: 19333617
Nat Struct Mol Biol. 2016 Jun;23(6):590-599
pubmed: 27183196
J Mol Cell Cardiol. 2013 Aug;61:28-33
pubmed: 23770352
J Biol Chem. 2013 Dec 13;288(50):35660-70
pubmed: 24165125
Biochemistry. 2010 Aug 3;49(30):6305-16
pubmed: 20583817
Nat Commun. 2015 Sep 03;6:8200
pubmed: 26334723
J Gen Physiol. 1992 Dec;100(6):905-32
pubmed: 1484285
Elife. 2019 Mar 21;8:
pubmed: 30896405
J Biol Chem. 2011 Aug 19;286(33):28811-20
pubmed: 21680748
Elife. 2015 Dec 23;4:e11306
pubmed: 26701913
Science. 2012 Feb 10;335(6069):686-90
pubmed: 22323814
Wellcome Open Res. 2019 Apr 1;4:63
pubmed: 31069261
Circulation. 1996 Sep 1;94(5):992-1002
pubmed: 8790037
Elife. 2017 Aug 15;6:
pubmed: 28826475
J Gen Physiol. 1997 Feb;109(2):273-86
pubmed: 9041455
Mol Cell Proteomics. 2015 Mar;14(3):596-608
pubmed: 25561500
Biochim Biophys Acta Biomembr. 2020 Jan 1;1862(1):183007
pubmed: 31202864
Channels (Austin). 2008 Sep-Oct;2(5):322-8
pubmed: 18989096
Cell Calcium. 2020 Mar;86:102158
pubmed: 31935590
Proc Natl Acad Sci U S A. 1993 May 1;90(9):3870-4
pubmed: 8483905
Circulation. 2012 May 1;125(17):2059-70
pubmed: 22456474
J Am Chem Soc. 2012 Jun 27;134(25):10345-8
pubmed: 22690931
Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1699-704
pubmed: 21209335
Nature. 1990 Mar 15;344(6263):242-5
pubmed: 2314460
Cell. 2003 Nov 14;115(4):377-88
pubmed: 14622593
Nat Commun. 2015 Oct 07;6:8512
pubmed: 26443885
Biochim Biophys Acta. 1988 Nov 22;945(2):298-306
pubmed: 3191125
Nat Commun. 2011;2:300
pubmed: 21556054
Nat Protoc. 2012 May 03;7(6):1042-51
pubmed: 22555243
Am J Physiol Cell Physiol. 2008 Sep;295(3):C732-9
pubmed: 18579798
Nat Rev Mol Cell Biol. 2007 Jan;8(1):74-84
pubmed: 17183362
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Virol. 2017 Oct 13;91(21):
pubmed: 28794042
Cell Calcium. 2020 Jan;85:102131
pubmed: 31794905
Nat Commun. 2017 Oct 31;8(1):1219
pubmed: 29089556
J Gen Physiol. 2018 Feb 5;150(2):211-224
pubmed: 29326133
J Biol Chem. 2017 Jun 23;292(25):10745-10752
pubmed: 28432123
J Biol Chem. 2009 Mar 6;284(10):6185-93
pubmed: 19141619
J Cardiovasc Electrophysiol. 2006 May;17 Suppl 1:S47-S56
pubmed: 16686682
Elife. 2013 Nov 26;2:e01293
pubmed: 24282236
FASEB J. 2015 Nov;29(11):4532-43
pubmed: 26174834
PLoS One. 2014 Oct 10;9(10):e109752
pubmed: 25303670
Drug Discov Today. 2012 Aug;17(15-16):850-60
pubmed: 22465171
Dev Cell. 2018 Nov 19;47(4):479-493.e7
pubmed: 30458139
Cell. 2005 Jun 17;121(6):937-50
pubmed: 15960980
J Biol Chem. 2011 Mar 18;286(11):8709-16
pubmed: 21216969
Biochem Biophys Res Commun. 2004 Feb 13;314(3):849-53
pubmed: 14741714
Circ Res. 2005 Jan 7;96(1):91-9
pubmed: 15550690
J Lipid Res. 2006 Jun;47(6):1118-27
pubmed: 16582420
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8097-102
pubmed: 22562795
Biochemistry. 2008 Jun 3;47(22):6081-7
pubmed: 18465877
Biochem Soc Trans. 2013 Feb 1;41(1):95-100
pubmed: 23356265
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17534-9
pubmed: 25422474
Biochim Biophys Acta. 2015 Apr;1853(4):841-9
pubmed: 25234412
Channels (Austin). 2016;10(2):75-7
pubmed: 26418268
Nature. 1997 Jun 5;387(6633):569-72
pubmed: 9177342
J Cell Biol. 2010 Dec 27;191(7):1229-38
pubmed: 21187327
Nat Commun. 2016 Jun 23;7:12035
pubmed: 27337590

Auteurs

Caglar Gök (C)

Institute of Cardiovascular & Medical Sciences, Sir James Black Building, University of Glasgow, Glasgow G12 8QQ, UK.

Fiona Plain (F)

School of Medicine, Ninewells Hospital, University of Dundee, Dundee DD1 9SY, UK.

Alan D Robertson (AD)

Institute of Cardiovascular & Medical Sciences, Sir James Black Building, University of Glasgow, Glasgow G12 8QQ, UK.

Jacqueline Howie (J)

Institute of Cardiovascular & Medical Sciences, Sir James Black Building, University of Glasgow, Glasgow G12 8QQ, UK.

George S Baillie (GS)

Institute of Cardiovascular & Medical Sciences, Sir James Black Building, University of Glasgow, Glasgow G12 8QQ, UK.

Niall J Fraser (NJ)

School of Medicine, Ninewells Hospital, University of Dundee, Dundee DD1 9SY, UK.

William Fuller (W)

Institute of Cardiovascular & Medical Sciences, Sir James Black Building, University of Glasgow, Glasgow G12 8QQ, UK. Electronic address: will.fuller@glasgow.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH